Zanubrutinib in patients with relapsed/refractory marginal zone lymphoma (MZL): final analysis of MAGNOLIA (BGB-3111-214)
Linton, Kim M Trotman, J McKay, P Ardeshna, K Iyengar, S Tedeschi, A Hu, B Leitch, S Jin, J Sun, M
Linton, Kim M
Trotman, J
McKay, P
Ardeshna, K
Iyengar, S
Tedeschi, A
Hu, B
Leitch, S
Jin, J
Sun, M
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Linton KM, Trotman J, McKay P, Ardeshna K, Iyengar S, Tedeschi A, et al. Zanubrutinib in patients with relapsed/refractory marginal zone lymphoma (MZL): Final analysis of MAGNOLIA (BGB-3111-214). British journal of haematology. 2023 APR;201:12-. PubMed PMID: WOS:001049283000015. English.